Chronic exposure to inorganic arsenic severely damages the central nervous system (CNS). Glutamate (GLU) is the major excitatory amino acid and is highly neurotoxic when levels in the synaptic cleft are not properly regulated by a family of Na 1 -dependent excitatory amino acid transporters. Within the cerebellum, the activity of the Bergmann glia Na 1 -dependent GLU/aspartate transporter (GLAST) excitatory amino acid transporter 1 (EAAT1/GLAST) accounts for more than 90% of GLU uptake. Because exposure to the metalloid arsenite results in CNS toxicity, we examined whether EAAT1/GLAST constitutes a molecular target. To this end, primary cultures of chick cerebellar Bergmann glial cells were exposed to sodium arsenite for 24 h, and EAAT1/GLAST activity was evaluated via 3 H-D-aspartate uptake. A sharp decrease in GLU transport was observed, and kinetic studies revealed protein kinase A, protein kinase C, and p38 mitogen-activated protein kinase-dependent decreases in K M and V max concomitant with diminished chglast transcription. To gain insight into the molecular mechanisms involved in these phenomena, we investigated the generation of reactive oxidative species and the lipid peroxidative damage caused by arsenite exposure. None of these responses were found, although we did observe an increase in nuclear factor (erythroidderived 2)-like 2 DNA-binding activity correlated with a rise in total glutathione levels. Our results clearly suggest that EAAT1/ GLAST is a molecular target of arsenite and support the critical involvement of glial cells in brain function and dysfunction.
Arsenic is one of the most important global environmental toxicants. Humans are exposed to arsenic through the intake of air, food, and water. Two main forms of inorganic arsenic (iAs) are found in the environment: arsenite and arsenate (Abernathy et al., 2003) . Most arsenicism is related to drinking tainted water over a long period of time, resulting in chronic toxicity associated with a wide range of health problems from skin cancer to cognitive impairment.
Epidemiological studies have suggested a correlation between iAs exposure and neurotoxicity (Hall, 2002; Rahman et al., 2001) . Neurotoxic effects from chronic iAs exposure have been reported in clinical cases and in animal models (Chattopadhyay et al., 2002; Rodríguez et al., 2001) . Acute occupational and environmental exposure to arsenic compounds results in encephalopathy and impairment of superior neurological functions, such as learning and memory (Danan et al., 1984) , concentration (Mukherjee et al., 2003) , verbal comprehension and attention (Calderon et al., 2001; Gerr et al., 2000) , diminished IQ (Calderon et al., 2001; Wasserman et al., 2004) , as well as peripheral neuropathy (Hafeman et al., 2005) both in adults and children. Studies in rodents have shown that arsenic exposure alters locomotor activity (Bardullas et al., 2009; Chattopadhyay et al., 2002; Itoh et al., 1990; Rodríguez et al., 2002; Schulz et al., 2002) and performance in several learning tasks (Nagaraja and Desiraju, 1994; Rodríguez et al., 2001 Rodríguez et al., , 2002 .
Arsenic exposure causes alterations in neurotransmitter systems, including the monoaminergic (Jana et al., 2006; Lin et al., 2007; Nagaraja and Desiraju, 1993; Rodríguez et al., 2001) , cholinergic (Kobayashi et al., 1987; Nagaraja and Desiraju, 1994) , gamma aminoisobutyric acidergic, and glutamatergic (Nagaraja and Desiraju, 1993) . It also affects brain development, specifically the Purkinje cells of the cerebellum (Dhar et al., 2005; Piao et al., 2005) . Neuronal damage has long been recognized to play a role in toxininduced loss of brain function. However, the mechanisms underlying the neurotoxic effects of iAs exposure have not been extensively investigated in vitro.
Glutamate (GLU) is the major excitatory neurotransmitter in the central nervous system (CNS). A family of sodiumdependent GLU transporters carries out the neurotransmitter removal from the synaptic cleft. The bulk of GLU transport is mediated through the excitatory amino acid transporter 1 (EAAT1/GLU/aspartate transporter [GLAST] ) expressed in Bergmann glial cells (BGC), which is of particular importance in the cerebellum. BGC are a special type of radial glia that extend their processes through the molecular layer of the cerebellar cortex, enwrapping excitatory and inhibitory synapses (Somogyi et al., 1990) . Recent evidence suggests that these cells might participate in neuronal communication and may also constitute a neuronal reservoir (Anthony et al., 2004; Malatesta et al., 2003) . BGC cultured from chick cerebellum are an excellent model for analyzing the molecular and cellular basis of glial-neuronal signaling . Acting through ionotropic and metabotropic receptors, GLU modifies gene expression patterns at the transcriptional and translational levels (Lopez-Bayghen and Ortega, 2010; LopezBayghen et al., 2007) . BGC express the GLU transporter EAAT1/GLAST, and the regulation of transcription and its activity has been described (Lopez-Bayghen and Ortega, 2004; Rosas et al., 2007) . Plasma membrane GLU transporters are also involved in the signaling transactions triggered by GLU (Gegelashvili et al., 2007; Zepeda et al., 2009) . Furthermore, BGC and Purkinje cell morphology is modified in vivo by the expression of Ca 2þ -permeable ionotropic glutamate receptors. Therefore, strong and continuous communication between these two cell types is expected (Watanabe, 2002) .
Few studies have explored the effects of arsenic exposure in astrocytes either in vivo or in vitro (Fauconneau et al., 2002; Opanashuk and Finkelstein, 1995) . Exposure of cultured rat astrocytes to high arsenite concentrations results in cytotoxicity and DNA damage (Catanzaro et al., 2010) . In general, glia cells and radial glia in particular play a very important role in the function and structure of glutamatergic synapses. The cellular basis of arsenic neurotoxicity remains poorly understood; therefore, in this study, we explored the effects of exposure to low iAs levels in cultured chick BGC. We focused on GLU transport because proper function is of paramount importance for a healthy neuron-glia relationship. Our experiments demonstrate that exposure to iAs downregulates EAAT1/GLAST activity and expression by a mechanism that involves several protein kinases, particularly p38 mitogen-activated protein kinase (p38 MAPK ).
MATERIALS AND METHODS
Reagents. Tissue culture reagents and TRIzol RNA extraction kit were obtained from GE Healthcare (Carlsbad, CA). SB202190 (4-[4-(4-fluorophenyl)-5-(4-pyridinyl)-1H-imidazol-2-yl] phenol) was obtained from Tocris-Cookson (Bristol, UK). GLU; H89 (N-[2-(p-bromocinnamylamino) ethyl]-5-isoquinolinesulfonamide dihydrochloride); PD98059 (2-[2-amino-3-methoxyphenil]-4H-1-benzopyran-4-one); UO126 (1,4-diamino-2,3-dicyano-1,4-bis-(o-aminophenylmercapto) butadiene monoethanolate); DTNB, 5,5#-dithiobis(2-nitrobenzoic acid); acetyl-CoA; N6,2#-0-dibutyryladenosine 3#, 5#-cyclic monophosphate sodium salt (dbcAMP); wortmannin (Wor); bisindolylmaleimide I (Bis I); thiobarbituric acid (TBA); ferrous ascorbate (Asc/Fe 2þ ); BSO, buthioninesulfoximine; TBHP, tert-butyl hydroperoxide; TBA; phorbol 12-myristate 13-acetate (TPA); 6b, (Danvers, MA) . Working standards of these arsenicals, which contained 1 lg of As/ml, were prepared daily from stock solutions. Sodium borohydride (NaBH 4 ) was obtained from EM Science (Gibbstown, NJ). Ultrapure phosphoric acid was purchased from J. T. Baker (Phillipsburg, NJ).
Cell culture and chemical treatment. Primary cultures of cerebellar BGC were prepared from 14-day-old chick embryos as previously described (Ortega et al., 1991) . Cells (1 3 10 6 ) were plated in plastic culture dishes or well plates (Corning, NY) in Dulbecco's modified Eagle's medium (DMEM) containing 10% fetal bovine serum (FBS), 2mM glutamine, and gentamicin (50 lg/ml) (all obtained from GE Healthcare) and used on the fourth or fifth day after culture. Before any treatment, confluent monolayers were switched to low-serum DMEM media (0.5% FBS) for 120 min and then treated as indicated in the figure legends. An aqueous sterile stock solution of sodium arsenite (1M Sigma-Aldrich Co.) was prepared and diluted with DMEM/0.5% fetal calf serum to obtain the desired final concentrations. For signaling analysis, antagonists or inhibitors were added 30 min before sodium arsenite treatment. Kinase activators or analogues were added to culture medium in concentrations and for the times indicated in the Table 1 .
Cytotoxicity assessment. Cell viability was measured after treatment with sodium arsenite (time and concentrations indicated in the figure legends) by the MTT reduction assay [3-(4, 5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide] (Calbiochem, Merck) performed as described by Mosmann (Mosmann, 1983) . Cells were seeded on 24-well plates in 500 ll of culture media and incubated for 24 h with sodium arsenite at 37°C in a 5% CO 2 atmosphere. After that, cells were treated with the MTT reagent (5 mg/ml) for approximately 4 h. An isopropanol:HCl solution was added to lyse the cells and solubilize the colored crystals. The optical density of the samples was determined at 630 nm using an ELISA plate reader Opsys MR (Dynex Technologies, Frankfurt, Germany). The results obtained by the MTT method were confirmed by the neutral red cytotoxicity assay, following the manufacturer instructions (Sigma-Aldrich Co.). Briefly, cells were seeded, incubated, and exposed to sodium arsenite and were treated with the neutral red reagent (0.33% in Dulbecco's PBS from Sigma-Aldrich Co.; 4 h). Cells were washed with the fixative solution and lysed; after resuspending with the solubilization solution, the optical density at 490 nm was determined using in the same ELISA plate reader mentioned before.
Transporter assays in BGC. The uptake of 3 H-D-aspartate (used as a nonmetabolizable analogue of L-GLU) was performed as detailed elsewhere (Ruiz and Ortega, 1995) . Briefly, the culture medium was exchanged with solution A [25mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid-Tris, 130mM NaCl, 5.4mM KCl, 1.8mM CaCl 2 , 0.8mM MgCl 2 , 33.3mM glucose, and 1mM NaHPO 4 , pH 7.4], and the cells were preincubated for 30 min at 37°C. Subsequently, this medium was exchanged with solution A containing 3 H-Daspartate (0.4 lCi/ml) and incubated for 20 min. Thereafter, the medium was removed by rapid aspiration and the monolayers were rapidly washed with icecold solution A and solubilized with 0.1M NaOH. Aliquots of the suspension were used for protein determination and liquid scintillation counting. As a control for the uptake assay, nontreated cells were incubated with 1mM GLU at 20°C for 30 min before the transport assay for an expected diminution in uptake (Gonzalez and Ortega, 1997) . All the uptake data were analyzed using the Sigma Plot software (Systat Software Inc., Point Richmond, CA) and the Prism, GraphPad Software (San Diego, CA). In kinetics experiments, 3 H-D-aspartate transport was analyzed after BGC cultures were incubated with sodium arsenite (1.5lM) during 24 h. Saturation curves were obtained by the addition of different concentrations of unlabeled D-aspartate and the kinetic constants (V max and K M ) determined with a nonlinear regression analysis using Prism GraphPad Software. Before analysis, each BGC sample was lysed in 1.25 ml of 0.5% solution of Triton X100 (Sigma-Aldrich Co.) in deionized water. The protein concentrations in BGC lysates were determined using the reducing agent compatible detergent compatible Protein Assay kit (BioRad Laboratories, Hercules, CA); bovine serum albumin was used for assay calibration. BGC lysates or supernatant media were digested in 3 ml of 2M ultrapure phosphoric acid at 90°C for 4 h; after that, samples were treated with 2% L-cysteine hydrochloride (EMD Chemicals Inc., Darmstadt, Germany) for 70 min at room temperature. Treatment with cysteine reduces all pentavalent As species to trivalency. Hydrides were generated from 0.5 ml aliquots of cysteine-treated samples by reaction with NaBH 4 in a Tris-HCl (Sigma-Aldrich Co.) buffer (pH 6) as previously described (Hernandez-Zavala et al., 2008) . Although HG-CT-AAS was developed for the oxidation state-specific speciation analysis of As, under current operating conditions, both above-described procedures determined total iAs (iAs III þ iAs ). For quality control during arsenic speciation analysis, sample aliquots spiked with arsenical standards were used. We obtained an accuracy of 99.6% and a variation coefficient < 10% in samples prepared by triplicate. For BGC lysates, arsenicals were expressed as ng As per mg of protein.
Reactive oxidative species detection. Reactive oxygen species (ROS) generation was evaluated by flow cytometry using 5-(and-6)-carboxy-2#,7#-dichlorofluorescein diacetate (DA) method based on the ROS-dependent oxidation of 2#, 7#-dichlorofluorescin diacetate (DCFH) to fluorescent dichlorofluorescein (Invitrogen Molecular Probes, Gaithersburg, MD) (Ali et al., 1992) . BGC cells (grown in p60 culture plates) were exposed to sodium arsenite (1.5lM) for the indicated times at 37°C. Then, DCFH-DA (15lM) was added and the incubation extended for 20 min. The fluorescence of the cells was immediately measured by flow cytometry (FACScalibur, Becton Dickinson, Franklin Lakes, NJ). TBHP (100lM for 60 min) was used to generate ROS (Adams et al., 1993) .
Assay for lipid peroxidation. Lipid peroxidation was determined in BGC based on the formation of TBA-reactive substance (TBARS). Malondialdehyde (MDA), other aldehydes, and lipid hydroxy-peroxides are able to form adducts with TBA (Sigma-Aldrich Co.). MDA concentration was used as an index of lipid peroxidation using the TBARS method (Buege and Aust, 1978) . Briefly, 0.5% TBA, 5 ll of 3.75% butylated hydroxytoluene (Sigma-Aldrich Co.) in methanol, and 5 ll of 1.5mM desferoxamine (Sigma-Aldrich Co.) were added to 1 ml of BGC suspension. Aliquots of the suspension were used for protein determination. Samples were then heated in a boiling water bath for 20 min and cooled, and the absorbance was measured at 532 nm using a spectrophotometer (UV-Vis Lambda-2S PerkinElmer, SpectraLab Scientific Inc., Canada).
Measurements are expressed as a percentage of the control. Asc/Fe 2þ (2.5mM for 30 min) was used to induce lipoperoxidative damage.
Determination of glutathione levels. Total glutathione (GSH) was measured, according to the method described by Beutler (Beutler and Kelly, 1963) , using 5,5#-dithiobis-(2-nitrobenzoic acid) (DTNB, known as Ellman's reagent, Sigma-Aldrich Co.) as key reagent. The absorbance of the yellowcolored complex was measured at 412 nm. The results were expressed as nmol per mg of protein. The GSH synthesis inhibitor BSO was added to a final concentration of 1mM.
Electrophoretic mobility shift assays. Nuclear extracts were prepared as described previously (López-Bayghen et al., 1996) . All buffers contained a protease inhibitor cocktail to prevent nuclear factor proteolysis. Protein concentration was measured by the Bradford method (Bradford, 1976) . Nuclear extracts (approximately 20 lg) from cells (treated as indicated) were incubated on ice with 1 lg of poly[deoxyinosinic-deoxycytidylic] as nonspecific competitor (Amersham Biosciences, Buckinghamshire, UK) and 2 ng of 32 Pend-labeled double-stranded oligonucleotides:
Nrf2: 5#-CTAGGCAGAATGCTGAGTCACGGTGGAA-3#, activator protein-1 (AP-1) (SV40): 5#-CTAGTTCCGGCTGAGTCAT-CAAGC-3#, and nuclear factor kappa B (NFjB): 5#-CTAGTTGAGGGGACTTTCC-CAGG -3#
The reaction mixtures were incubated for 15 min on ice and electrophoresed through 6% polyacrylamide gels using a low-ionic strength 0.53 Tris/Borate/ EDTA buffer. The gels were dried and exposed to an autoradiographic film or scanned with a Typhoon Optical Scanner (Amersham Biosciences). Complex specificity for AP-1 (SV40) and NFjB was assessed before by competition assays and immunoEMSA (Aguirre et al., 2000; Mendez et al., 2005) and for Nfr2 (Supplementary fig. 1 ).
Quantitative reverse transcription-PCR. Real-time quantitative reverse transcription-PCR (qRT-PCR) was performed by a two-step method.
Complementary DNA was generated from 1 lg of total RNA by Improm-II reverse transcription system (Promega, Madison, WI) with oligo(dT) 18 (Fermentas, Glen Burnie, MA) as a primer and according to the manufacturer's instructions. PCR was performed by QuantiTect SYBR Green PCR Kit (Qiagen, Valencia, CA) in a reaction volume of 20 ll. Triplicate samples were subjected to quantitative PCR (qPCR) using 7300 Real-Time PCR System (Applied Biosystems). The qPCR profile consisted of an initial denaturation step at 95°C for 10 min followed by 35 cycles of 95°C for 30 s, 60°C for 1 min, and 72°C for 30 s. A melt curve stage was added. We used the following specific primers to amplify: chglast, GLASTF, 5#-GGCTGCGGGCATTCCTC-3# and GLASTR, 5#-CGGAGACGATCCAA-GAACCA-3#. S17 chick ribosomal protein messenger RNA (mRNA) was used as an internal control. The oligonucleotides used were (1pM, each) S17s, 5#-CCGCTGGATGCGCTTCATCAG-3# and S17as, 5#-TACACCCGTCTGGG-CAAC-3#. PCR products were sequenced in order to verify their identity. The relative abundance of GLAST mRNA is expressed as sample versus a control in comparison to S17 chick ribosomal mRNA and was calculated using the 2 À DDCT method. Data are presented as mean values ± SEs and analyzed by ANOVA (p < 0.05 was considered statistically significant).
Transient transfections and reporter assays. The plasmid p800GLAST-CAT contains the 5# noncoding region from the chglast (515 to þ 248, total 763 bp) cloned in the pCAT-BASIC vector (Promega) amplified by reverse PCR (Lopez-Bayghen et al., 2003) . Michael Gredes from Dr Yuspa laboratory at NIH kindly donated the reporter vectors TPA-responsive element chloramphenicol acetyltransferase (TRE-CAT) and cAMP-responsive element (CRE)-CAT. Both contain the structural gene for CAT under the control of the Herpes virus thymidine kinase promoter and five SV40 AP-1 sites cloned upstream for TRE-CAT or five CRE elements for CRE-CAT (Rutberg et al., 1999) . pGL2-hARE-LUC contains the NQO-hARE site [antioxidant response element from nicotinamide adenine dinucleotide phosphate:quinone oxidoreductase gene] cloned in the pGL2-Basic vector was kindly donated by Dr Phil Jaiswal University of Maryland, School of Medicine (Dhakshinamoorthy and Jaiswal, 2000) . Three copies of NFjB element were cloned in pCAT-Promoter (Promega) to produce NFjB-CAT (Mendez et al., 2005) . Transient transfection assays were performed in 80% confluent BGC cultures using a calcium phosphate protocol with the indicated amount of purified plasmids. Under such conditions, the transfection efficacy was close to 50% determined by a transfection control (b-gal). Treatments were done 4 h posttransfection, and cell harvesting for reporter assays was performed 24 h posttransfection. Protein lysates were obtained as follows: cells were harvested in cold PBS buffer, lysed with one freeze-thaw cycle, and centrifuged at 12,000 3 g for 1 min. Equal amounts of protein lysates (80 lg) were incubated with 0.25 lCi of 14 Cchloramphenicol (50 mCi/mmol) (Amersham Biosciences) and 0.8mM acetylCoA (Sigma-Aldrich Co.) at 37°C. Acetylated forms were separated by thinlayer chromatography and quantified using a Typhoon radioactive image analyzer and the ImageQuant software (GE Healthcare). CAT activities were expressed as the acetylated fraction corrected for the activity in the pCAT-Basic vector and are expressed as relative activities to nontreated control cell lysates. The luciferase activity was determined using the Luciferase Assay System (Promega). 24 h posttransfection, cells were processed for luciferase measurement. Briefly, protein lysates were obtained from cells harvested in cold PBS and lysed in 100 ll of Reporter Lysis Buffer (Promega). Equal amounts of protein lysates (~70 lg) were incubated with luciferase assay reagent. Light detection was performed in a FluoroSkan Ascent FL 374 (Labsystems), and activity values were normalized to protein content.
Statistical analysis. In all cases, data are expressed as the mean values (average) ± the SEs. A nonparametric one-way ANOVA (Kruskal-Wallis test) was performed to determine significant differences between conditions. When these analyses indicated significance (at the 0.05 level), a Dunn's post hoc test was used to determine which conditions were significantly different from each other with Prism, GraphPad Software.
RESULTS

iAs Exposure Impairs GLU Transport
To explore if EAAT1/GLAST constitutes a molecular target for iAs, primary cultures of BGC were exposed to iAs, and the EAAT1/GLAST transporter activity was evaluated via 3 H-Daspartate uptake assays. A clear decrease in GLU transport was evident in cells treated with 1.5lM of sodium arsenite (iAs) for 24 and 48 h, a concentration that is epidemiologically relevant in terms of human exposure (Fig. 1A, left panel) . Treatment with sodium arsenite in concentrations as low as 0.5lM for 24 h also affected the transporter activity (Fig. 1A, right panel) . Kinetic analysis of the transporter showed an iAs-dependent decrease in V max and K M (Fig. 1B) .
MTT assays were performed to rule out decreased cell viability being responsible for the diminished transporter activity. As shown in Figure 1C , no cell death is associated with exposure to 1.5lM of sodium arsenite for 24 h. MTT values were unchanged when cells were iAs treated for 24 h and changed to iAs-free media for an additional 24 h (Fig. 1C,  right panel) . These results were corroborated using the neutral red method with the same results (data not shown).
To gain insight into the molecular mechanisms of iAs action on EAAT1/GLAST activity, we analyzed arsenic metabolism in BGC. Two parameters were taken into account. Concentration in cells (ng As per mg of protein) gives potential information for dose-effect relation in tissue burdens of arsenic species as a function of time. Relative proportions of arsenic species allow us to assess the capacity of cells to methylate iAs as a function of time. As clearly shown in Figure 2 , BGC accumulates iAs as well as its metabolites methylarsenic and DMA, suggesting that generation of ROS or even lipoperoxidative damages might be plausible. However, neither an increase in ROS nor a clear augmentation of lipid peroxidation was detected (Figs. 3A and 3B ). Nevertheless, we were able to detect a rise in GSH levels, which seems to be dependent on de novo synthesis as it is sensitive to BSO, an inhibitor of gamma-glutamylcysteine synthetase (Fig. 3C ). This response correlates well with a specific increase in the DNAbinding activity of nuclear factor (erythroid-derived 2)-like 2 (Nrf2), the transcription factor that acts as master regulator of the antioxidant response. Under the same treatment conditions, we observed a sevenfold increase in the reporter vector pGL2-hARE-LUC activity (Figs. 3D and 3E ). As expected, there is an increase in AP-1 complexes, accompanied by a clear augmentation of the transcription of a TRE-driven construct (TRE-CAT) (Figs. 3D and 3E ). There is no change in NFjB protein-DNA complexes from control or iAs-treated cells (Fig. 3D) and NFjB-CAT did not indicate any change in activity (Fig. 3E ).
Long-term Exposure to iAs Results in chglast Transcriptional
Downregulation To further explore the mechanism by which iAs impairs GLU uptake, we quantified the transporter's mRNA levels by real-time PCR (qRT-PCR). The primers shown in panel A of Figure 4 were used. As depicted in panel C of Figure 4 , a sharp decrease in chglast mRNA was detected. At this stage, we could not rule out a decrease in chglast mRNA half-life due to iAs exposure, so we decided to evaluate the transcriptional activity of the chglast promoter . The construct is shown in panel D of Figure 4 . Note the presence of putative DNA-binding sites for several transcription factors. Exposure of transfected BGC to iAs for 12 and 24 h resulted in decreased chglast promoter activity. As an experimental control, cells were exposed to 1mM GLU for 2 h . These results suggest that EAAT1/GLAST transcription is the molecular target of iAs (Fig. 4) .
Signaling Involved in iAs-Dependent Transcriptional Control
Previous work from our group established the pivotal role of protein kinase C (PKC) in the regulation of EAAT1/ GLAST activity (Gonzalez and Ortega, 1997) and gene expression (Espinoza-Rojo et al., 2000; Lopez-Bayghen et al., 2003; Lopez-Bayghen and Ortega, 2004) . Furthermore, iAs activates PKC, phosphatidyl inositol 3 kinase (PI3K), and extracellular regulated kinase (ERK) (Chen et al., 2000; Qian et al., 2003; Zhou et al., 2004) . Therefore, we decided to explore if the effects of iAs exposure in BGC involve PKC activation. To this end, we evaluated the iAs effect in 3 H-D-aspartate uptake in the presence of the PKC inhibitor Bis I (see Table 1 ). As shown in panel A of Figure 5 , Bis I treatment prevents iAs-mediated decrease in GLU uptake.
FIG. 1.
Exposure to iAs impairs GLU transport in BGC with no effect on cell survival. (A) 3 H-D-aspartate uptake assays in BGC following exposure to sodium arsenite (iAs) for the indicated times (hours, left) and at the indicated concentrations (range 0.1-5lM, right panel). Nontreated cells (NT) were incubated with 1mM GLU for 30 min as control for the uptake assay. (B) Effect of iAs on the kinetics of the Na þ -dependent 3 H-D-aspartate transport. BGC cultures were incubated with 1.5lM of sodium arsenite for 24 h prior to the assay. (C) Cell viability determination after iAs treatment for 24 (left) or 48 h with media change after 24 h of treatment. In all cases, error bars represent SE of the mean from three independent experiments performed in quadruplicate; nonparametric one-way ANOVA was used to determine significant differences *p < 0.05 and ***p < 0.001 in panel (A).
ARSENITE DOWNREGULATES EAAT1/GLAST
PKC is a member of the AGC family (Pearce et al., 2010) and is often activated in a PI3K-dependent manner. Nevertheless, preincubation with the PI3K blocker Wor did not prevent the iAs effect, suggesting that the ERK pathway is not involved. In fact, treatment with the MEK blockers PD98059 and UO126 did not abolish the iAs effect (Fig. 5B) . The same results were obtained in the corresponding gene reporter assays (Fig. 5C) .
Although less characterized, the cAMP pathway is also involved in EAAT1/GLAST regulation (Espinoza-Rojo et al., 2000) . The protein kinase A (PKA) blocker H89 (20lM, 30 min before iAs) was effective in preventing the iAs effect on 3 H-D-aspartate uptake (Fig. 6A) . Similarly, a nonhydrolyzable cAMP analogue (dbcAMP), as well as a PKA activator Forskolin (100lM, 24 h), mimicked the iAs effect in both uptake and gene reporter assays (Fig. 6B) . As expected, both iAs and dbcAMP are capable of increasing the transcription of a CRE-driven reporter (CRE-CAT in Fig. 6C ).
Another member of the mitogen-activated kinases involved in excitotoxic damage and in GLU-dependent transcriptional control could participate in the iAs effect (Zepeda et al., 2008) . As clearly shown in Figure 7 , treatment with 1lM of the p38 MAPK inhibitor SB2021 at 30 min before iAs prevented the iAs effect by 3 H-D-aspartate uptake as well as the transcriptional control level, suggesting direct involvement of this kinase in the iAs molecular mechanism of action.
DISCUSSION
Cognitive deficiencies associated with exposure to arsenic have been well documented (Rodríguez et al., 2002) . Glutamatergic transmission is critical for synaptic plasticity, and the associated molecular transactions correlate with memory acquisition and formation (Gibbs et al., 2008; McKinney, 2010) . Astrocytes are the most abundant cells in the CNS, yet have been regarded over the years as supportive elements. A well-established exception is the functional role for glia cells in the glutamatergic system. These cells participate in neurotransmitter recycling via the GLU/glutamine shuttle, by which glial cells clear the synaptic space by taking up the transmitter, transforming it into glutamine, and finally releasing it back to the neurons that hydrolyze it to replenish the synaptic vesicles (Bak et al., 2006) . A metabolic coupling between glia and glutamatergic neurons has been elegantly described as the ''astrocyte/neuron lactate shuttle'' (Pellerin et al., 2007) . In this context, we hypothesized that astrocytes, rather than neurons, could be the target of iAs toxicity in the CNS, particularly at very low doses. To challenge our idea, we decided to explore a fundamental astrocytic function, GLU uptake.
Exposure of astrocytes to low, but environmentally relevant, concentrations of iAs impairs GLU transport due to diminished transcription of the chglast gene. In this scenario, GLU accumulates in the synaptic space leading first 
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to the spillover of the transmitter and activation of extrasynaptic receptors (Takayasu et al., 2009) and in the long term to the transcriptional downregulation of glast, amplifying the effect. In the absence of EAAT1/GLAST, a mild motor discoordination is observed along with dramatic increases in cerebellar damage after brain insults (Watase et al., 1998) . Surprisingly, in EAAT1/ GLAST (À/À) mice, neither a morphological difference in the cerebellar cortex cytoarchitecture nor a difference in the peak amplitude of parallel fiber excitatory postsynaptic currents was found (Takayasu et al., 2005) .
The signaling cascade affected by iAs in BGC is PKC dependent but intracellular Ca 2þ independent (data not shown). Therefore, one could imagine that a novel PKC isoform may be involved. Supporting this interpretation is the fact that overexpression of the PKCe isoform in BGC diminishes chglast transcription (Lopez-Bayghen and Ortega, 2004) . Interestingly, iAs response involves p38 MAPK , a known PKCe substrate (Garczarczyk et al., 2009 ). p38 MAPK s have been reported to phosphorylate a broad range of nuclear proteins, including transcription factors and regulators of ARSENITE DOWNREGULATES EAAT1/GLAST chromatin remodeling (Cuadrado and Nebreda, 2010) . We are currently exploring those that have putative binding sites located in the chglast promoter (Fig. 4) .
The fact that BGC take up and metabolize iAs suggests that the ROS generation could be a consequence of iAs exposure. We could not detect ROS generation in the treated cells. This unexpected result might be explained by the kinetics of ROS generation, although the fact that iAs treatment did not increase NFjB DNA-binding or transcriptional activity makes this unlikely. An alternative explanation for this result is the iAs-induced increase in GSH levels (Fig. 3C) , an effect that is also reflected at the nuclear level with the increase in Nrf2 DNA-binding and transcriptional activity. Current work in our laboratory is 
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aimed at the identification of genes modulated in an Nrf2-mediated, iAs-dependent manner, one of which could be EAAT1/GLAST.
In summary, we demonstrate that glial cells are susceptible to iAs toxicity and that downregulation of EAAT1/GLAST expression contributes and amplifies neuronal damage. Future work will address other glial functions affected by iAs exposure, including metabolic coupling, to fully characterize the molecular toxicology of iAs in the brain. Table 1 for experimental details.
FIG. 6. PKA is activated in iAs-treated BGC. (A)
3 H-D-aspartate uptake assays in control or iAs-exposed cells with the PKA inhibitor H89 or the PKA activators, dibutyryl cAMP (dbcAMP) and Forskolin (FSK). (B) and (C) Confluent cultures were transfected with 3 lg of p800GLAST-CAT or CRE-CAT; in both cases, cells were treated as indicated (Table 1 and ''Materials and Methods'' section).**p < 0.01 and ***p < 0.001, ANOVA.
ARSENITE DOWNREGULATES EAAT1/GLAST 547 SUPPLEMENTARY DATA Supplementary data are available online at http://toxsci. oxfordjournals.org/. 
